| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.65M | 40.85M | 52.46M | 52.71M | 40.32M | 32.58M |
| Gross Profit | 16.26M | 13.62M | 22.44M | 21.12M | 16.91M | 13.14M |
| EBITDA | 577.00K | -3.29M | 6.10M | 7.48M | 5.92M | 3.38M |
| Net Income | -2.67M | -5.13M | 1.97M | 3.12M | 947.00K | 9.00K |
Balance Sheet | ||||||
| Total Assets | 74.75M | 71.82M | 81.09M | 84.24M | 78.58M | 80.20M |
| Cash, Cash Equivalents and Short-Term Investments | 16.21M | 7.85M | 9.65M | 12.80M | 9.57M | 14.56M |
| Total Debt | 23.75M | 17.02M | 18.63M | 19.98M | 21.50M | 28.22M |
| Total Liabilities | 38.69M | 33.89M | 36.01M | 40.27M | 37.92M | 41.30M |
| Stockholders Equity | 36.07M | 37.93M | 45.09M | 43.97M | 40.66M | 38.90M |
Cash Flow | ||||||
| Free Cash Flow | -268.00K | 2.54M | -474.00K | 5.56M | 3.71M | 1.66M |
| Operating Cash Flow | 760.00K | 4.08M | 1.73M | 7.54M | 5.11M | 3.26M |
| Investing Cash Flow | 20.76M | -1.51M | -2.03M | -1.61M | -2.56M | -1.60M |
| Financing Cash Flow | -13.75M | -4.34M | -2.70M | -2.67M | -7.52M | 3.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £126.19M | 10.13 | 20.23% | 3.00% | 16.79% | 26.31% | |
65 Neutral | £11.31M | 25.58 | 11.90% | 5.12% | 186.12% | 294.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | £327.84M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
52 Neutral | £24.10M | -20.02 | 1.54% | ― | -4.67% | 590.48% | |
51 Neutral | £30.67M | -3.94 | -7.20% | 0.39% | -5.19% | 11.73% |